The CLOCK Study - A Human Dietary Intervention Study on Peripheral Circadian Clocks and Energy Metabolism
NCT ID: NCT02487576
Last Updated: 2025-08-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2014-01-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Time-restricted Feeding as a Dietary Strategy Against Metabolic Disturbances in Humans
NCT04351672
Food and Circadian Timing
NCT04743271
Pilot Study of Time Restricted Feeding as a Weight Loss Intervention
NCT03571048
Randomized Study of Daytime vs. Delayed Eating: Effect on Weight and Metabolism
NCT04414644
Fasted Evening Exercise: Performance and Compensatory Eating
NCT04742530
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Carbohydrate-rich_Fat-rich (HC_HF)
Isocaloric carbohydrate-rich meals in the morning (06.00 am - 01.30 pm) and isocaloric fat-rich meals in the evening (04.30 pm - 10.00 pm) for 4 weeks
No interventions assigned to this group
Fat-rich_Carbohydrate-rich (HF_HC)
Isocaloric fat-rich meals in the morning (06.00 am - 01.30 pm) and isocaloric carbohydrate-rich meals in the evening (04.30 pm - 10.00 pm) for 4 weeks
Carbohydrate-rich (HC)
65% Carbohydrate; 20% Fat; 15% Protein
Fat-rich (HF)
35% Carbohydrate; 50% Fat; 15% Protein
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Carbohydrate-rich (HC)
65% Carbohydrate; 20% Fat; 15% Protein
Fat-rich (HF)
35% Carbohydrate; 50% Fat; 15% Protein
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Normal glucose tolerance determined in a 75g-oral glucose tolerance test
* Impaired fasting glucose determined in a 75g-oral glucose tolerance test
* Impaired glucose tolerance determined in a 75g-oral glucose tolerance test
Exclusion Criteria
* Men suffering from diseases or conditions that might influence the outcome of the study. Of special interest are diseases that influence body weight regulation (enteropathy, malabsorption, hepatopathy, renal disease, endocrine disorders, diabetes mellitus, eating disorders, heart disease etc.). Also men suffering from coagulopathy, apoplexy and myocardial infarction are excluded from the study.
* Men suffering from psychiatric disease
* Planned changes in physical activity during the study
* Participation in other clinical studies within the last three months
* Weight changes \> 2 kg within 2 months prior to screening day
* Men unable to give an informed consent
* Men unable to engage in the dietary interventions
* Men following a special diet
18 Years
70 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
German Federal Ministry of Education and Research
OTHER_GOV
Charite University, Berlin, Germany
OTHER
Heidelberg University
OTHER
Max-Planck Institute of Molecular Cell Biology and Genetics
OTHER
German Institute of Human Nutrition
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Dr. med. Andreas F. H. Pfeiffer
Prof. Dr. med Andreas F.H. Pfeiffer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andreas FH Pfeiffer, Prof. Dr.
Role: STUDY_DIRECTOR
German Institute of Human Nutrition
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
German Institute of Human Nutrition
Potsdam, , Germany
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Kessler K, Hornemann S, Petzke KJ, Kemper M, Kramer A, Pfeiffer AF, Pivovarova O, Rudovich N. The effect of diurnal distribution of carbohydrates and fat on glycaemic control in humans: a randomized controlled trial. Sci Rep. 2017 Mar 8;7:44170. doi: 10.1038/srep44170.
Kessler K, Hornemann S, Petzke KJ, Kemper M, Markova M, Rudovich N, Grune T, Kramer A, Pfeiffer AFH, Pivovarova-Ramich O. Diurnal distribution of carbohydrates and fat affects substrate oxidation and adipokine secretion in humans. Am J Clin Nutr. 2018 Dec 1;108(6):1209-1219. doi: 10.1093/ajcn/nqy224.
Kessler K, Gerl MJ, Hornemann S, Damm M, Klose C, Petzke KJ, Kemper M, Weber D, Rudovich N, Grune T, Simons K, Kramer A, Pfeiffer AFH, Pivovarova-Ramich O. Shotgun Lipidomics Discovered Diurnal Regulation of Lipid Metabolism Linked to Insulin Sensitivity in Nondiabetic Men. J Clin Endocrinol Metab. 2020 May 1;105(5):dgz176. doi: 10.1210/clinem/dgz176.
Kessler K, Hornemann S, Rudovich N, Weber D, Grune T, Kramer A, Pfeiffer AFH, Pivovarova-Ramich O. Saliva Samples as A Tool to Study the Effect of Meal Timing on Metabolic And Inflammatory Biomarkers. Nutrients. 2020 Jan 28;12(2):340. doi: 10.3390/nu12020340.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DDG021023
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
DFG grant KFO218 PF164/16-1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.